中国非透析慢性病患者治疗坚持度表的开发和验证:一项混合方法研究

Yi Cui^1,2, Xiaoyan Li¹, Na Liu²

¹Department of Nephrology, Tangdu Hospital, The Fourth Military Medical University (Air Force Medical University), Xi'an, People's Republic of China.

Patient preference and adherence

|March 11, 2026

概括

一个新的尺度,非透析慢性病患者的治疗坚持度 (TAS-NCKD),有效地衡量慢性病患者的坚持度. 这种工具有助于更好的自我管理,并可能减缓疾病的进展.

科学领域:

腎臟病學 (nephrology) 是一種醫學專業.
公共卫生公共卫生
心理测量心理测量心理测量

背景情况:

慢性病 (CKD) 是一个重大的全球健康挑战.
非透析CKD患者的有效管理在很大程度上依赖于遵守复杂的治疗计划.
目前的评估工具缺乏精确的依从性评估和对CKD有针对性的干预所需的多维性.

研究的目的:

开发和验证一种特定于疾病的仪器,用于评估非透析CKD患者的治疗坚持.
为非透析CKD患者创建治疗坚持度表 (TAS-NCKD).
为准确的遵守评估和在CKD管理中提供有针对性的干预提供一个工具.

主要方法:

在中国进行了一项横截面混合方法研究.
项目生成涉及范围审查和Delphi专家轮.
心理测量验证使用了三轮调查 (n=160,350,370),评估可行性,可靠性,有效性和歧视性.

主要成果:

最终的TAS-NCKD包括5个维度的45个项目,证明了高可行性 (92.5%的完成率,<18分钟的完成时间).
证实了卓越的可靠性 (克朗巴赫的α=0.955,分半=0.968,测试-重新测试=0.836).
确立了强大的有效性 (规模级CVI=0.992,项目级CVI=0.875-1),具有理想的项目特征曲线和179点的最佳切线.

结论:

TAS-NCKD是评估中国非透析慢性病患者的治疗坚持度的有效和可靠的尺度.
这种经过验证的工具提供了有针对性的见解,以加强患者的自我管理策略.
TAS-NCKD有可能有助于减缓慢性病的进展.

关键词:

中国中国中国中国.慢性脏疾病慢性脏疾病不进行透析的患者.规模的发展和验证.治疗的坚持治疗的坚持

相关概念视频

01:28

Chronic Kidney Disease III: Interprofessional Care

565

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...

565

01:25

Chronic Kidney Disease I: Introduction

936

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...

936

01:18

Chronic Kidney Disease IV: Nursing Management

523

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...

523

01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

285

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.

285

01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

290

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...

290

01:24

Chronic Kidney Disease II: Clinical Manifestations

864

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...

864